Nuermberger, E.L., Chaisson, R.E. Restocking the tuberculosis drug arsenal. Nat Med 30, 642–643 (2024). https://doi.org/10.1038/s41591-024-02840-y
Archives: Publications
Publications
The magnitude of unfavorable tuberculosis treatment outcomes and their relation with baseline undernutrition and sustained undernutrition among children receiving tuberculosis treatment in central Ethiopia
Burusie A, Enquesilassie F, Salazar-Austin N, Addissie A. The magnitude of unfavorable tuberculosis treatment outcomes and their relation with baseline undernutrition and sustained undernutrition among children receiving tuberculosis treatment in central Ethiopia. Heliyon. 2024;10(6):e28040. Published 2024 Mar 16. doi:10.1016/j.heliyon.2024.e28040
US Guidelines Fall Short on Short-Course Tuberculosis-Preventive Therapy
Krishnan S, Chaisson RE. US Guidelines Fall Short on Short-Course Tuberculosis-Preventive Therapy. Clin Infect Dis. 2024;78(3):514-517. doi:10.1093/cid/ciad659
Adverse Pregnancy Outcomes Among Women with Human Immunodeficiency Virus Taking Isoniazid Preventive Therapy During the First Trimester
Gupta A, Hughes MD, Cruz JL, et al. Adverse Pregnancy Outcomes Among Women with Human Immunodeficiency Virus Taking Isoniazid Preventive Therapy During the First Trimester. Clin Infect Dis. 2024;78(3):667-673. doi:10.1093/cid/ciad583
What is next for BCG revaccination to prevent tuberculosis?
White RG, Fiore-Gartland AJ, Hanekom WA, et al. What is next for BCG revaccination to prevent tuberculosis?. Lancet Respir Med. 2024;12(3):e7-e8. doi:10.1016/S2213-2600(24)00009-2
Factors associated with non-completion of TB preventive treatment in Brazil
Cola JP, Nascimento do Prado T, Alves KBA, et al. Factors associated with non-completion of TB preventive treatment in Brazil. Int J Tuberc Lung Dis. 2023;27(3):215-220. doi:10.5588/ijtld.22.0571
Travel distance to rifampicin-resistant tuberculosis treatment and its impact on loss to follow-up: the importance of continued RR-TB treatment decentralization in South Africa
McNabb KC, Bergman AJ, Patil A, et al. Travel distance to rifampicin-resistant tuberculosis treatment and its impact on loss to follow-up: the importance of continued RR-TB treatment decentralization in South Africa. BMC Public Health. 2024;24(1):578. Published 2024 Feb 23. doi:10.1186/s12889-024-17924-0
Comparison of 3 optimized delivery strategies for completion of isoniazid-rifapentine (3HP) for tuberculosis prevention among people living with HIV in Uganda: A single-center randomized trial
Semitala FC, Kadota JL, Musinguzi A, et al. Comparison of 3 optimized delivery strategies for completion of isoniazid-rifapentine (3HP) for tuberculosis prevention among people living with HIV in Uganda: A single-center randomized trial. PLoS Med. 2024;21(2):e1004356. Published 2024 Feb 20. doi:10.1371/journal.pmed.1004356
Active case-finding of tuberculosis compared with symptom-driven standard of care: a modelling analysis
Malhotra A, Ryckman TS, Johnson K, et al. Active case-finding of tuberculosis compared with symptom-driven standard of care: a modelling analysis. Int J Epidemiol. 2024;53(2):dyae019. doi:10.1093/ije/dyae019
Decline in prevalence of tuberculosis following an intensive case finding campaign and the COVID-19 pandemic in an urban Ugandan community
Kendall EA, Kitonsa PJ, Nalutaaya A, Robsky KO, Erisa KC, Mukiibi J, Cattamanchi A, Kato-Maeda M, Katamba A, Dowdy D. Decline in prevalence of tuberculosis following an intensive case finding campaign and the COVID-19 pandemic in an urban Ugandan community. Thorax. 2024 Jan 22:thorax-2023-220047. doi: 10.1136/thorax-2023-220047. Epub ahead of print. PMID: 38050134.